Bao Jianfeng, Tu Hui, Li Jing, Li Yijia, Yu Shan, Gao Jingpi, Lei Kun, Zhang Fengshou, Li Jinghua
School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, China.
Office of Science & Technology, Henan University of Science and Technology, Luoyang, China.
Front Bioeng Biotechnol. 2022 Sep 12;10:991005. doi: 10.3389/fbioe.2022.991005. eCollection 2022.
Phase change materials (PCMs) are materials that are stimulated by the external enthalpy change (temperature) to realize solid-liquid and liquid-solid phase transformation. Due to temperature sensitivity, friendly modification, and low toxicity, PCMs have been widely used in smart drug delivery. More often than not, the drug was encapsulated in a solid PCMs matrix, a thermally responsive material. After the trigger implementation, PCMs change into a solid-liquid phase, and the loading drug is released accordingly. Therefore, PCMs can achieve precise release control with different temperature adjustments, which is especially important for small molecular drugs with severe side effects. The combination of drug therapy and hyperthermia through PCMs can achieve more accurate and effective treatment of tumor target areas. This study briefly summarizes the latest developments on PCMs as smart gate-keepers for anti-tumor applications in light of PCMs becoming a research hot spot in the nanomedicine sector in recent years.
相变材料(PCMs)是一类通过外部焓变(温度)刺激来实现固-液和液-固相变的材料。由于具有温度敏感性、易于改性且毒性低等特点,相变材料已广泛应用于智能药物递送领域。通常情况下,药物被封装在固态相变材料基质(一种热响应材料)中。触发后,相变材料转变为固-液相,负载的药物随之释放。因此,通过不同的温度调节,相变材料可以实现精确的释放控制,这对于副作用严重的小分子药物尤为重要。通过相变材料将药物治疗与热疗相结合,可以更准确有效地治疗肿瘤靶区。鉴于近年来相变材料成为纳米医学领域的研究热点,本研究简要总结了相变材料作为抗肿瘤应用智能守门人的最新进展。